The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 study of combined therapy FOLFOX with dabrafenib and cetuximab/panitumumab as first-line treatment for patients with metastatic colorectal cancer MSS with BRAF V600E mutation.
 
Mikhail Fedyanin
No Relationships to Disclose
 
Evgenia Kuzmina
No Relationships to Disclose
 
Ilya Pokataev
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Eisai; Merck; Novartis; Pfizer; Pierre Fabre; Roche; Swixx BioPharma
 
Marina Lyadova
No Relationships to Disclose
 
Tatiana Antonova
No Relationships to Disclose
 
Lyudmila Zhukova
No Relationships to Disclose
 
Polina Feoktistova
No Relationships to Disclose
 
Katerina Grechukhina
No Relationships to Disclose
 
Daniil Stroyakovskiy
No Relationships to Disclose
 
Elena Glazkova
No Relationships to Disclose
 
Anastasia Rays
No Relationships to Disclose
 
Nikolay Sokolov
No Relationships to Disclose